Serial Sampling of the Small Airway Epithelium to Identify Persistent Smoking-dysregulated Genes

• Published in: American journal of respiratory and critical care medicine Vol. 208; no. 7; pp. 780 - 790
• Main Authors: Strulovici-Barel, Yael, Rostami, Mahboubeh R, Kaner, Robert J, Mezey, Jason G, Crystal, Ronald G
• Format: Journal Article
• Language: English
• Published: United States American Thoracic Society 01-10-2023
• Subjects: Airway management; Epithelium - metabolism; Genes; Humans; Original; Pathogenesis; Respiratory diseases; Smoking; Smoking - adverse effects; Smoking - genetics; Smoking - metabolism; Smoking Cessation; Tobacco Smoking; Transcriptome; Tripartite Motif Proteins; Ubiquitin-Protein Ligases - genetics; Ubiquitin-Protein Ligases - metabolism; transcriptome; common versus individual dysregulation; cessation; repeated measures
• ISSN: 1073-449X; 1535-4970; 1535-4970
• DOI: 10.1164/rccm.202204-0786OC

The small airway epithelium (beyond the sixth generation), the initiation site of smoking-induced airway disorders, is highly sensitive to the stress of smoking. Because of variations over time in smoking habits, the small airway epithelium transcriptome is dynamic, fluctuating not only among smokers but also within each smoker.
To perform accurate assessment of the smoking-related dysregulation of the human small airway epithelium despite the variation of smoking within the same individual and of the effects of smoking cessation on the dysregulated transcriptome.
We conducted serial sampling of the same smokers and nonsmoker control subjects over time to identify persistent smoking dysregulation of the biology of the small airway epithelium over 1 year. We conducted serial sampling of smokers who quit smoking, before and after smoking cessation, to assess the effect of smoking cessation on the smoking-dysregulated genes.
Repeated measures ANOVA of the small airway epithelium transcriptome sampled four times in the same individuals over 1 year enabled the identification of 475 persistent smoking-dysregulated genes. Most genes were normalized after 12 months of smoking cessation; however, 53 (11%) genes, including
,
,
, and
, remained persistently abnormally expressed. Dysregulated pathways enriched with the nonreversible genes included xenobiotic metabolism signaling, bupropion degradation, and nicotine degradation.
Analysis of repetitive sampling of the same individuals identified persistent smoking-induced dysregulation of the small airway epithelium transcriptome and the effect of smoking cessation. These results help identify targets for the development of therapies that can be applicable to smoking-related airway diseases.